Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Aldevron Names Dr. Thomas Lynch Vice President of Sales and Client Development

Aldevron
Posted on: 22 Aug 17

Thomas Lynch, Ph.D., has been named Vice President of Sales and Client Development of Aldevron, a global provider of plasmid DNA manufacturing, protein production and antibody discovery services. Lynch will guide the sales strategy and growth for Aldevron’s product lines in nucleic acids, proteins, and antibodies. His responsibilities include growing the company’s sales team to further support Aldevron’s worldwide preclinical and GMP client base.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170822005623/en/

Tom Lynch (Photo: Aldevron)

Lynch has 10 years of biotechnology sales experience and holds a Ph.D. in biochemistry. He has most recently served as Vice President of Sales for DNASTAR, a leading sequence analysis software company. Before joining DNASTAR he held roles of increasing responsibility at Aldevron, most recently as Director of Client Relations.

“We are excited to welcome Tom to this senior leadership position,” said Michael Chambers, the company’s CEO. “Tom’s proven track record of growing sales in the biotechnology industry as well as his prior experience and success at Aldevron will enable him and his team to provide the highest level of service to our growing client base.” Chambers added that Lynch’s addition to the executive team is a key part of the company’s strategy to meet the requirements of the rapidly expanding antibody, cell and gene therapy industries.

“It is exciting to join Aldevron at this important point in the company’s growth,” said Lynch. “Aldevron has built an outstanding reputation over the past two decades by serving clients throughout the world. The company is uniquely positioned to take advantage of the growth the industry will see as products move through late phase clinical trials to commercialization. I look forward to returning to a truly phenomenal company.”

Lynch holds a Bachelor of Science degree in Biochemistry from the University of Minnesota Twin Cities in Minneapolis, and a Ph.D. in Biochemistry from the University of Illinois in Champaign, Illinois.

About Aldevron

Aldevron serves the biotechnology industry with custom production of nucleic acids, proteins, and antibodies. Thousands of clients use Aldevron-produced plasmid DNA, RNA and gene editing enzymes for research, clinical, and commercial applications. Aldevron’s clients are developing revolutionary treatments in many fields including oncology, neuroscience, infectious disease and rare diseases. Aldevron specializes in GMP manufacturing and is known for inventing the GMP-SourceTM quality system. Company headquarters are in Fargo, N.D., with additional facilities in Madison, Wisc., and Freiburg, Germany.

Learn more about Aldevron

View source version on businesswire.com: http://www.businesswire.com/news/home/20170822005623/en/

Business Wire
www.businesswire.com

Last updated on: 22/08/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.